During the past decade, Saint Vincent Hospital Cancer Center at Oconto Falls conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 53 clinical trials were completed, i.e. on average, 70.7% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 29 clinical trials were completed. i.e. 93.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Vincent Hospital Cancer Center at Oconto Falls" #1 sponsor was "National Cancer Institute (NCI)" with 77 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "Gynecologic Oncology Group" with 8 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Vincent Hospital Cancer Center at Oconto Falls" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Saint Vincent Hospital Cancer Center at Oconto Falls" are "Invasive Breast Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "HER2/Neu Negative" (6 trials). Many other conditions were trialed in "Saint Vincent Hospital Cancer Center at Oconto Falls" in a lesser frequency.

Most popular intervention types in "Saint Vincent Hospital Cancer Center at Oconto Falls" are "Drug" (101 trials), "Other" (96 trials), "Biological" (61 trials), "Procedure" (32 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Quality-of-Life Assessment" (46 trials), "Questionnaire Administration" (24 trials), "Paclitaxel" (21 trials) and "Carboplatin" (19 trials). Other intervention names were less common.

The vast majority of trials in "Saint Vincent Hospital Cancer Center at Oconto Falls" are 103 trials for "All" genders, 23 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Vincent Hospital Cancer Center at Oconto Falls". undefined are not yet recruiting, 25 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Saint Vincent Hospital Cancer Center at Oconto Falls, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Vincent Hospital Cancer Center at Oconto Falls, 1 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".